FABP5 regulates an immunosuppressive microenvironment in hepatocellular carcinoma through the NF-κB/PD-L1 axis
Rui An, Shibing Hou, Min Hong, Jiaorong Zhen, Zhijuan Wang, Haoming Huang, Weixuan Zhao, Mianmian Liao, Weiqu Yuan, Danping Huang, Lanlan Chen · 2026
Read FABP5 regulates an immunosuppressive microenvironment in hepatocellular carcinoma through the NF-κB/PD-L1 axis by Rui An, Shibing Hou, Min Hong, Jiaorong Zhen, Zhijuan Wang, Haoming Huang, Weixuan Zhao, Mianmian Liao, Weiqu Yuan, Danping Huang, Lanlan Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13623383.txt.
Description
Rui An and a large team investigate a fat-handling protein called FABP5 in hepatocellular carcinoma, the main form of liver cancer. The protein was suspected of helping tumours hide from the immune system, which would make it a drug target. The study mixes public cancer data, single-cell analysis, cell experiments, and computer drug screening.
FABP5 levels ran high in liver tumours and marked worse survival, and the protein sat in support cells and immune cells called macrophages inside tumours. Silencing it in cancer cells slowed growth and movement. Tumours rich in the protein showed more immune entry yet more immune brakes, including higher PD-L1, a shield molecule tumours use against attack. Follow-up tests confirmed the protein raises that shield through an inflammatory pathway. A screened compound, CZS-241, bound the protein stably in simulations, and the authors propose it as a lead for drug development.
Catalog record
| CREATOR | Rui An, Shibing Hou, Min Hong, Jiaorong Zhen, Zhijuan Wang, Haoming Huang, Weixuan Zhao, Mianmian Liao, Weiqu Yuan, Danping Huang, Lanlan Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |